SWA
IBB icon

Stratos Wealth Advisors’s iShares Biotechnology ETF IBB Stock Holding History

Stratos Wealth Advisors’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$670K Buy
3,970
+35
+0.9% +$5.99K 0.04% 341
2025
Q4 		$664K Sell
3,935
-51
-1% -$8.28K 0.03% 380
2025
Q3 		$575K Buy
3,986
+154
+4% +$21K 0.03% 431
2025
Q2 		$485K Sell
3,832
-62
-2% -$7.61K 0.03% 456
2025
Q1 		$498K Buy
3,894
+1
+0% +$136 0.03% 431
2024
Q4 		$515K Sell
3,893
-109
-3% -$15.3K 0.02% 462
2024
Q3 		$583K Hold
4,002
– – 0.03% 461
2024
Q2 		$549K Sell
4,002
-23
-0.6% -$3.07K 0.03% 449
2024
Q1 		$552K Buy
4,025
+222
+6% +$30.3K 0.03% 437
2023
Q4 		$517K Sell
3,803
-621
-14% -$75.8K 0.03% 458
2023
Q3 		$541K Sell
4,424
-280
-6% -$35.6K 0.04% 418
2023
Q2 		$597K Sell
4,704
-89
-2% -$11.6K 0.04% 404
2023
Q1 		$619K Buy
4,793
+43
+0.9% +$5.63K 0.05% 380
2022
Q4 		$624K Buy
4,750
+949
+25% +$123K 0.05% 363
2022
Q3 		$445K Sell
3,801
-19
-0.5% -$2.36K 0.05% 367
2022
Q2 		$449K Sell
3,820
-234
-6% -$27.8K 0.04% 380
2022
Q1 		$528K Sell
4,054
-7,578
-65% -$987K 0.04% 371
2021
Q4 		$1.77M Sell
11,632
-5,876
-34% -$910K 0.13% 203
2021
Q3 		$2.83M Sell
17,508
-4,883
-22% -$822K 0.24% 115
2021
Q2 		$3.66M Sell
22,391
-1,593
-7% -$245K 0.32% 83
2021
Q1 		$3.61M Buy
23,984
+5,860
+32% +$931K 0.38% 71
2020
Q4 		$2.75M Buy
18,124
+4,570
+34% +$653K 0.38% 70
2020
Q3 		$1.83M Buy
13,554
+9,564
+240% +$1.3M 0.45% 58
2020
Q2 		$545K Buy
3,990
+978
+32% +$125K 0.17% 134
2020
Q1 		$325K Sell
3,012
-65
-2% -$7.48K 0.23% 101
2019
Q4 		$371K Sell
3,077
-106
-3% -$11.8K 0.21% 106
2019
Q3 		$317K Sell
3,183
-329
-9% -$34.4K 0.12% 176
2019
Q2 		$383K Buy
3,512
+8
+0.2% +$851 0.15% 145
2019
Q1 		$392K Sell
3,504
-220
-6% -$24.1K 0.21% 125
2018
Q4 		$359K Buy
+3,724
New +$395K 0.24% 124

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Stratos Wealth Advisors's IBB Position: Q1 2026 in Review

Stratos Wealth Advisors increased its iShares Biotechnology ETF (IBB) stake by 0.89% in Q1 2026, buying an estimated $5.99K and bringing the position to 3,970 shares worth $670K. The position accounts for 0.04% of the portfolio, ranked #341.

Stratos Wealth Advisors first reported a position in IBB in Q4 2018 and has held it in 30 quarters since. The position peaked at $3.66M in Q2 2021. 919 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

  • Stratos Wealth Advisors held 3,970 shares of iShares Biotechnology ETF worth $670K as of Q1 2026.
  • Stratos Wealth Advisors bought 35 iShares Biotechnology ETF shares in Q1 2026, an estimated $5.99K.
  • iShares Biotechnology ETF made up 0.04% of Stratos Wealth Advisors's portfolio in Q1 2026, its #341 holding.
  • Stratos Wealth Advisors first reported a position in iShares Biotechnology ETF in Q4 2018 and has held it in 30 quarters since.
  • Stratos Wealth Advisors's iShares Biotechnology ETF position peaked at $3.66M in Q2 2021.
  • 919 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on Stratos Wealth Advisors's 13F filing for Q1 2026, filed 28 Apr 2026.